Journal
BIOCHEMICAL JOURNAL
Volume 478, Issue 24, Pages 4187-4202Publisher
PORTLAND PRESS LTD
DOI: 10.1042/BCJ20200910
Keywords
-
Categories
Funding
- Cancer Research UK [C67500/A29686]
- National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's as well as St Thomas' NHS Foundation Trust and King's College London
- NIHR Clinical Research Facility
Ask authors/readers for more resources
The human immune system has evolved multiple strategies to diversify the CD8(+) T cell response against pathogens and aberrations of self, by presenting a variety of antigenic peptide sequences through MHC class I complexes. Recent progress in evaluating the prevalence and immunological relevance of unconventional antigen peptides, as well as the cross-recognition of antigenic peptides by CD8(+) T cell T cell receptors, has been a controversial but important area of study.
Throughout its evolution, the human immune system has developed a plethora of strategies to diversify the antigenic peptide sequences that can be targeted by the CD8(+) T cell response against pathogens and aberrations of self. Here we provide a general overview of the mechanisms that lead to the diversity of antigens presented by MHC class I complexes and their recognition by CD8(+) T cells, together with a more detailed analysis of recent progress in two important areas that are highly controversial: the prevalence and immunological relevance of unconventional antigen peptides; and cross-recognition of antigenic peptides by the T cell receptors of CD8(+) T cells.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available